| 0 |
THYROID ATROPHY |
10 |
0.1064 |
| 1 |
EXPLODING HEAD SYNDROME |
1 |
0.0312 |
| 2 |
CONCOMITANT DRUG EFFECT DECREASED |
1 |
0.0233 |
| 3 |
PHARYNGEAL ENANTHEMA |
1 |
0.0164 |
| 4 |
RESPIRATORY DYSKINESIA |
1 |
0.0108 |
| 5 |
NASAL DISCOMFORT |
85 |
0.0107 |
| 6 |
STATUS MIGRAINOSUS |
1 |
0.0062 |
| 7 |
URINARY RETENTION POSTOPERATIVE |
1 |
0.0061 |
| 8 |
SWELLING OF NOSE |
1 |
0.0058 |
| 9 |
CATHETER SITE NODULE |
1 |
0.0052 |
| 10 |
VIRAL PERICARDITIS |
1 |
0.0048 |
| 11 |
RHINALGIA |
10 |
0.0036 |
| 12 |
DYSGEUSIA |
259 |
0.0035 |
| 13 |
URINE CALCIUM INCREASED |
1 |
0.0032 |
| 14 |
COLD-STIMULUS HEADACHE |
1 |
0.0031 |
| 15 |
DERMOID CYST |
1 |
0.0030 |
| 16 |
TACHYPHYLAXIS |
1 |
0.0029 |
| 17 |
BURNING SENSATION MUCOSAL |
1 |
0.0028 |
| 18 |
VIRAL MYOCARDITIS |
1 |
0.0027 |
| 19 |
SENSATION OF BLOOD FLOW |
1 |
0.0026 |
| 20 |
SINUS PAIN |
6 |
0.0026 |
| 21 |
HUMIDITY INTOLERANCE |
1 |
0.0025 |
| 22 |
VITAMIN B12 DEFICIENCY |
10 |
0.0025 |
| 23 |
EXPOSURE VIA EYE CONTACT |
1 |
0.0024 |
| 24 |
LACK OF SPONTANEOUS SPEECH |
1 |
0.0023 |
| 25 |
PHARYNGEAL ULCERATION |
3 |
0.0023 |
| 26 |
ESSENTIAL HYPERTENSION |
4 |
0.0022 |
| 27 |
UPPER-AIRWAY COUGH SYNDROME |
18 |
0.0022 |
| 28 |
DRAINAGE |
1 |
0.0020 |
| 29 |
SENSORIMOTOR DISORDER |
1 |
0.0020 |
| 30 |
MALABSORPTION |
10 |
0.0019 |
| 31 |
INFUSION SITE CELLULITIS |
1 |
0.0019 |
| 32 |
PRODUCT CLOSURE ISSUE |
1 |
0.0018 |
| 33 |
TASTE DISORDER |
36 |
0.0018 |
| 34 |
BURN ORAL CAVITY |
1 |
0.0017 |
| 35 |
THROAT IRRITATION |
75 |
0.0017 |
| 36 |
MEAN PLATELET VOLUME INCREASED |
1 |
0.0017 |
| 37 |
PROCTALGIA |
10 |
0.0016 |
| 38 |
PRODUCT INEFFECTIVE |
1 |
0.0013 |
| 39 |
OESOPHAGEAL PERFORATION |
1 |
0.0012 |
| 40 |
INFECTED BITE |
1 |
0.0012 |
| 41 |
TONGUE PRURITUS |
1 |
0.0012 |
| 42 |
PHARYNGEAL HYPOAESTHESIA |
1 |
0.0011 |
| 43 |
PRODUCT AFTER TASTE |
1 |
0.0010 |
| 44 |
INFUSION SITE NODULE |
1 |
0.0010 |
| 45 |
INFUSION SITE DISCOMFORT |
1 |
0.0010 |
| 46 |
NASAL INFLAMMATION |
1 |
0.0009 |
| 47 |
INNER EAR DISORDER |
1 |
0.0009 |
| 48 |
CATHETER SITE DISCHARGE |
1 |
0.0009 |
| 49 |
BENIGN NEOPLASM |
1 |
0.0009 |
| 50 |
PRODUCT TASTE ABNORMAL |
12 |
0.0009 |
| 51 |
REGURGITATION |
3 |
0.0009 |
| 52 |
CARBON DIOXIDE DECREASED |
1 |
0.0009 |
| 53 |
ADMINISTRATION SITE PAIN |
1 |
0.0009 |
| 54 |
JC POLYOMAVIRUS TEST POSITIVE |
1 |
0.0009 |
| 55 |
MYOCLONUS |
10 |
0.0008 |
| 56 |
POST-ACUTE COVID-19 SYNDROME |
1 |
0.0008 |
| 57 |
HYPERACUSIS |
3 |
0.0008 |
| 58 |
PARANASAL SINUS DISCOMFORT |
3 |
0.0008 |
| 59 |
ENDOCRINE DISORDER |
1 |
0.0008 |
| 60 |
OROPHARYNGEAL DISCOMFORT |
7 |
0.0008 |
| 61 |
NASAL DISORDER |
2 |
0.0008 |
| 62 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
2 |
0.0008 |
| 63 |
ANION GAP INCREASED |
1 |
0.0007 |
| 64 |
THERAPEUTIC PROCEDURE |
1 |
0.0007 |
| 65 |
MAST CELL ACTIVATION SYNDROME |
1 |
0.0007 |
| 66 |
INJECTION SITE HYPOAESTHESIA |
1 |
0.0007 |
| 67 |
MENTAL FATIGUE |
1 |
0.0007 |
| 68 |
ORAL MUCOSAL ERYTHEMA |
1 |
0.0006 |
| 69 |
INHIBITORY DRUG INTERACTION |
1 |
0.0006 |
| 70 |
PRE-ECLAMPSIA |
3 |
0.0006 |
| 71 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
44 |
0.0006 |
| 72 |
COSTOCHONDRITIS |
1 |
0.0006 |
| 73 |
MITRAL VALVE PROLAPSE |
1 |
0.0006 |
| 74 |
TROPONIN I INCREASED |
1 |
0.0006 |
| 75 |
MYOCARDIAL NECROSIS MARKER INCREASED |
1 |
0.0006 |
| 76 |
HYPERLIPIDAEMIA |
7 |
0.0006 |
| 77 |
BLADDER NEOPLASM |
1 |
0.0006 |
| 78 |
EAR PRURITUS |
2 |
0.0006 |
| 79 |
HAEMORRHOIDS |
11 |
0.0006 |
| 80 |
NASAL OEDEMA |
1 |
0.0006 |
| 81 |
OESOPHAGEAL SPASM |
1 |
0.0005 |
| 82 |
CEREBROSPINAL FLUID LEAKAGE |
1 |
0.0005 |
| 83 |
NASAL OBSTRUCTION |
1 |
0.0005 |
| 84 |
PHARYNGEAL SWELLING |
5 |
0.0005 |
| 85 |
EMPYEMA |
1 |
0.0005 |
| 86 |
SLEEP DEFICIT |
1 |
0.0005 |
| 87 |
MIGRAINE |
45 |
0.0005 |
| 88 |
TENSION HEADACHE |
2 |
0.0005 |
| 89 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 90 |
FAECES PALE |
1 |
0.0004 |
| 91 |
TEMPERATURE REGULATION DISORDER |
1 |
0.0004 |
| 92 |
FACIAL PAIN |
4 |
0.0004 |
| 93 |
BRAIN FOG |
7 |
0.0004 |
| 94 |
SNEEZING |
10 |
0.0004 |
| 95 |
SUSPECTED OFF LABEL USE |
2 |
0.0004 |
| 96 |
BURNING SENSATION |
31 |
0.0004 |
| 97 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
2 |
0.0004 |
| 98 |
RETCHING |
9 |
0.0004 |
| 99 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 100 |
FIBROMYALGIA |
10 |
0.0004 |
| 101 |
INCORRECT DOSAGE ADMINISTERED |
2 |
0.0004 |
| 102 |
CATHETER SITE HAEMORRHAGE |
1 |
0.0004 |
| 103 |
EAR DISCOMFORT |
4 |
0.0004 |
| 104 |
GASTROINTESTINAL MOTILITY DISORDER |
2 |
0.0004 |
| 105 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 106 |
EAR CONGESTION |
1 |
0.0004 |
| 107 |
PLEURITIC PAIN |
1 |
0.0004 |
| 108 |
ELECTRIC SHOCK SENSATION |
1 |
0.0004 |
| 109 |
ANGINA PECTORIS |
10 |
0.0003 |
| 110 |
VOMITING PROJECTILE |
1 |
0.0003 |
| 111 |
ESCHERICHIA SEPSIS |
1 |
0.0003 |
| 112 |
HYPOTHYROIDISM |
11 |
0.0003 |
| 113 |
PULMONARY PAIN |
1 |
0.0003 |
| 114 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 115 |
NEGATIVE THOUGHTS |
1 |
0.0003 |
| 116 |
DRUG EFFECT LESS THAN EXPECTED |
5 |
0.0003 |
| 117 |
INFUSION SITE REACTION |
1 |
0.0003 |
| 118 |
LACRIMATION INCREASED |
10 |
0.0003 |
| 119 |
NASAL DRYNESS |
2 |
0.0003 |
| 120 |
SWELLING OF EYELID |
2 |
0.0003 |
| 121 |
BLADDER PAIN |
1 |
0.0003 |
| 122 |
SALIVARY HYPERSECRETION |
3 |
0.0003 |
| 123 |
TRANSIENT ISCHAEMIC ATTACK |
10 |
0.0003 |
| 124 |
SINUS CONGESTION |
4 |
0.0003 |
| 125 |
HYPOPNOEA |
1 |
0.0003 |
| 126 |
LYMPHADENOPATHY |
10 |
0.0003 |
| 127 |
HEAD DISCOMFORT |
5 |
0.0003 |
| 128 |
FIBRIN D DIMER INCREASED |
1 |
0.0003 |
| 129 |
MONOCYTE COUNT INCREASED |
1 |
0.0003 |
| 130 |
PAROSMIA |
2 |
0.0003 |
| 131 |
CATHETER SITE INFECTION |
1 |
0.0003 |
| 132 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
1 |
0.0003 |
| 133 |
TRIGEMINAL NEURALGIA |
1 |
0.0002 |
| 134 |
RHINORRHOEA |
16 |
0.0002 |
| 135 |
OSTEOPOROSIS |
10 |
0.0002 |
| 136 |
NASAL CONGESTION |
14 |
0.0002 |
| 137 |
SLEEP TERROR |
1 |
0.0002 |
| 138 |
TONGUE DISCOMFORT |
1 |
0.0002 |
| 139 |
INCORRECT DRUG ADMINISTRATION RATE |
1 |
0.0002 |
| 140 |
RECTAL HAEMORRHAGE |
10 |
0.0002 |
| 141 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 142 |
DIVERTICULUM INTESTINAL |
1 |
0.0002 |
| 143 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 144 |
ILEUS PARALYTIC |
1 |
0.0002 |
| 145 |
BLOOD PRESSURE DIASTOLIC INCREASED |
1 |
0.0002 |
| 146 |
HYPOKALAEMIA |
10 |
0.0002 |
| 147 |
OROPHARYNGEAL PAIN |
20 |
0.0002 |
| 148 |
ORAL DISCOMFORT |
3 |
0.0002 |
| 149 |
EPISTAXIS |
16 |
0.0002 |
| 150 |
PHOTOPHOBIA |
4 |
0.0002 |
| 151 |
THERAPEUTIC RESPONSE SHORTENED |
7 |
0.0002 |
| 152 |
HUMERUS FRACTURE |
1 |
0.0002 |
| 153 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 154 |
SINUS DISORDER |
4 |
0.0002 |
| 155 |
PETIT MAL EPILEPSY |
1 |
0.0002 |
| 156 |
EYE IRRITATION |
11 |
0.0002 |
| 157 |
POOR QUALITY PRODUCT ADMINISTERED |
2 |
0.0002 |
| 158 |
THROAT TIGHTNESS |
5 |
0.0002 |
| 159 |
NORMAL NEWBORN |
1 |
0.0002 |
| 160 |
GASTROOESOPHAGEAL REFLUX DISEASE |
14 |
0.0002 |
| 161 |
DEVICE DEFECTIVE |
3 |
0.0002 |
| 162 |
HYPERVENTILATION |
1 |
0.0002 |
| 163 |
STRESS CARDIOMYOPATHY |
1 |
0.0002 |
| 164 |
COLD SWEAT |
3 |
0.0002 |
| 165 |
PLEURISY |
1 |
0.0002 |
| 166 |
TOOTHACHE |
3 |
0.0002 |
| 167 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
9 |
0.0002 |
| 168 |
CONCOMITANT DISEASE AGGRAVATED |
1 |
0.0002 |
| 169 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
1 |
0.0002 |
| 170 |
EYE SWELLING |
6 |
0.0002 |
| 171 |
NECK PAIN |
9 |
0.0002 |
| 172 |
AGEUSIA |
4 |
0.0002 |
| 173 |
PHOTOPSIA |
1 |
0.0002 |
| 174 |
MYDRIASIS |
2 |
0.0002 |
| 175 |
VOMITING |
71 |
0.0002 |
| 176 |
SKIN MASS |
1 |
0.0001 |
| 177 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 178 |
DYSPHAGIA |
14 |
0.0001 |
| 179 |
PERIPHERAL COLDNESS |
2 |
0.0001 |
| 180 |
RESPIRATION ABNORMAL |
1 |
0.0001 |
| 181 |
DROOLING |
1 |
0.0001 |
| 182 |
THERMAL BURN |
1 |
0.0001 |
| 183 |
PARAESTHESIA ORAL |
2 |
0.0001 |
| 184 |
ORAL DISORDER |
1 |
0.0001 |
| 185 |
GENERAL SYMPTOM |
1 |
0.0001 |
| 186 |
HYPOAESTHESIA ORAL |
2 |
0.0001 |
| 187 |
AORTIC ANEURYSM |
1 |
0.0001 |
| 188 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 189 |
LOW DENSITY LIPOPROTEIN INCREASED |
1 |
0.0001 |
| 190 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 191 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 192 |
SENSORY DISTURBANCE |
2 |
0.0001 |
| 193 |
RHINITIS |
1 |
0.0001 |
| 194 |
MENTAL IMPAIRMENT |
3 |
0.0001 |
| 195 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 196 |
SWELLING FACE |
8 |
0.0001 |
| 197 |
PERICARDITIS |
2 |
0.0001 |
| 198 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 199 |
CARDIAC OPERATION |
1 |
0.0001 |
| 200 |
MUSCLE STRAIN |
1 |
0.0001 |
| 201 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 202 |
NAIL DISORDER |
1 |
0.0001 |
| 203 |
BLOOD CALCIUM INCREASED |
1 |
0.0001 |
| 204 |
PRODUCT COMMUNICATION ISSUE |
1 |
0.0001 |
| 205 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 206 |
DRUG INEFFECTIVE |
147 |
0.0001 |
| 207 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 208 |
PANIC ATTACK |
4 |
0.0001 |
| 209 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 210 |
ANAPHYLACTIC REACTION |
6 |
0.0001 |
| 211 |
APPENDICITIS |
1 |
0.0001 |
| 212 |
OCULAR HYPERAEMIA |
5 |
0.0001 |
| 213 |
EYE INFLAMMATION |
1 |
0.0001 |
| 214 |
ATRIAL FIBRILLATION |
10 |
0.0001 |
| 215 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 216 |
NAUSEA |
81 |
0.0001 |
| 217 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 218 |
DRY THROAT |
1 |
0.0001 |
| 219 |
INJURY ASSOCIATED WITH DEVICE |
2 |
0.0001 |
| 220 |
EUPHORIC MOOD |
1 |
0.0001 |
| 221 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 222 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 223 |
TENDERNESS |
1 |
0.0001 |
| 224 |
BIPOLAR DISORDER |
1 |
0.0001 |
| 225 |
DENTAL CARIES |
1 |
0.0001 |
| 226 |
TOOTH DISORDER |
2 |
0.0001 |
| 227 |
SKIN INFECTION |
1 |
0.0001 |
| 228 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 229 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 230 |
MYOCARDITIS |
1 |
0.0001 |
| 231 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 232 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
4 |
0.0001 |
| 233 |
SPINAL PAIN |
1 |
0.0001 |
| 234 |
MUSCLE RIGIDITY |
1 |
0.0001 |
| 235 |
WRIST FRACTURE |
1 |
0.0001 |
| 236 |
PHARYNGITIS |
1 |
0.0001 |
| 237 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
2 |
0.0001 |
| 238 |
PALLOR |
2 |
0.0001 |
| 239 |
FEELING COLD |
2 |
0.0001 |
| 240 |
WOUND |
2 |
0.0001 |
| 241 |
PAIN IN JAW |
2 |
0.0001 |
| 242 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 243 |
HYPERSOMNIA |
2 |
0.0001 |
| 244 |
ANOSMIA |
1 |
0.0001 |
| 245 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 246 |
CHEST DISCOMFORT |
7 |
0.0001 |
| 247 |
ILLNESS |
7 |
0.0001 |
| 248 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
3 |
0.0001 |
| 249 |
HYPOAESTHESIA |
10 |
0.0001 |
| 250 |
HYPERTENSION |
14 |
0.0001 |
| 251 |
INJECTION SITE RASH |
2 |
0.0001 |
| 252 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 253 |
MENINGIOMA |
1 |
0.0001 |
| 254 |
PNEUMOTHORAX |
1 |
0.0001 |
| 255 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
3 |
0.0001 |
| 256 |
MANIA |
1 |
0.0001 |
| 257 |
HEADACHE |
38 |
0.0001 |
| 258 |
EYE PRURITUS |
2 |
0.0001 |
| 259 |
CANDIDA INFECTION |
1 |
0.0001 |
| 260 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
1 |
0.0001 |
| 261 |
DEVICE USE ERROR |
2 |
0.0001 |
| 262 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 263 |
SKIN BURNING SENSATION |
4 |
0.0001 |
| 264 |
THINKING ABNORMAL |
1 |
0.0001 |
| 265 |
BLISTER |
3 |
0.0001 |
| 266 |
EYE PAIN |
3 |
0.0001 |
| 267 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 268 |
MUSCULOSKELETAL DISORDER |
1 |
0.0001 |
| 269 |
FEELING JITTERY |
1 |
0.0001 |
| 270 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 271 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 272 |
GLAUCOMA |
1 |
0.0001 |
| 273 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 274 |
DYSTONIA |
1 |
0.0001 |
| 275 |
EAR PAIN |
1 |
0.0001 |
| 276 |
PALPITATIONS |
6 |
0.0001 |
| 277 |
SURGERY |
3 |
0.0001 |
| 278 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 279 |
COMPLICATION OF DEVICE INSERTION |
1 |
0.0001 |
| 280 |
DYSKINESIA |
2 |
0.0000 |
| 281 |
DISCOMFORT |
3 |
0.0000 |
| 282 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 283 |
FEELING HOT |
3 |
0.0000 |
| 284 |
PULMONARY HYPERTENSION |
1 |
0.0000 |
| 285 |
DERMATITIS |
1 |
0.0000 |
| 286 |
ABDOMINAL DISCOMFORT |
8 |
0.0000 |
| 287 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 288 |
MENTAL DISORDER |
2 |
0.0000 |
| 289 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 290 |
INTENTIONAL PRODUCT MISUSE |
4 |
0.0000 |
| 291 |
APPLICATION SITE PAIN |
1 |
0.0000 |
| 292 |
TACHYCARDIA |
4 |
0.0000 |
| 293 |
ORAL PAIN |
1 |
0.0000 |
| 294 |
THERAPEUTIC RESPONSE UNEXPECTED |
2 |
0.0000 |
| 295 |
THERAPY NON-RESPONDER |
2 |
0.0000 |
| 296 |
PRURITUS |
17 |
0.0000 |
| 297 |
DIZZINESS |
22 |
0.0000 |
| 298 |
VISION BLURRED |
6 |
0.0000 |
| 299 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 300 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 301 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 302 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 303 |
TREMOR |
7 |
0.0000 |
| 304 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 305 |
RASH ERYTHEMATOUS |
2 |
0.0000 |
| 306 |
PRESYNCOPE |
1 |
0.0000 |
| 307 |
NEURALGIA |
1 |
0.0000 |
| 308 |
OFF LABEL USE |
36 |
0.0000 |
| 309 |
HEART RATE INCREASED |
4 |
0.0000 |
| 310 |
DRY EYE |
2 |
0.0000 |
| 311 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 312 |
INJECTION SITE SWELLING |
3 |
0.0000 |
| 313 |
HYPOPHAGIA |
1 |
0.0000 |
| 314 |
ERYTHEMA |
8 |
0.0000 |
| 315 |
ANAPHYLACTIC SHOCK |
1 |
0.0000 |
| 316 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 317 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 318 |
DEAFNESS |
1 |
0.0000 |
| 319 |
SPEECH DISORDER |
2 |
0.0000 |
| 320 |
PARAESTHESIA |
6 |
0.0000 |
| 321 |
JOINT STIFFNESS |
1 |
0.0000 |
| 322 |
GASTRITIS |
1 |
0.0000 |
| 323 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 324 |
CONSTIPATION |
8 |
0.0000 |
| 325 |
MALAISE |
16 |
0.0000 |
| 326 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 327 |
FLATULENCE |
2 |
0.0000 |
| 328 |
LETHARGY |
2 |
0.0000 |
| 329 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
7 |
0.0000 |
| 330 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 331 |
DYSSTASIA |
1 |
0.0000 |
| 332 |
DYSPHONIA |
2 |
0.0000 |
| 333 |
CHILLS |
4 |
0.0000 |
| 334 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 335 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 336 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 337 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 338 |
WHEEZING |
2 |
0.0000 |
| 339 |
ARTHRALGIA |
14 |
0.0000 |
| 340 |
CATARACT |
2 |
0.0000 |
| 341 |
RESPIRATORY DISORDER |
1 |
0.0000 |
| 342 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 343 |
APHASIA |
1 |
0.0000 |
| 344 |
VERTIGO |
2 |
0.0000 |
| 345 |
NASOPHARYNGITIS |
6 |
0.0000 |
| 346 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 347 |
CHEST PAIN |
6 |
0.0000 |
| 348 |
SWELLING |
3 |
0.0000 |
| 349 |
ANXIETY |
9 |
0.0000 |
| 350 |
CYSTITIS |
1 |
0.0000 |
| 351 |
MOOD SWINGS |
1 |
0.0000 |
| 352 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 353 |
NIGHT SWEATS |
1 |
0.0000 |
| 354 |
CHOLELITHIASIS |
1 |
0.0000 |
| 355 |
EYE DISORDER |
1 |
0.0000 |
| 356 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 357 |
VIRAL INFECTION |
1 |
0.0000 |
| 358 |
GAIT INABILITY |
1 |
0.0000 |
| 359 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 360 |
ACCIDENTAL EXPOSURE TO PRODUCT |
3 |
0.0000 |
| 361 |
HAEMORRHAGE |
3 |
0.0000 |
| 362 |
RASH MACULAR |
1 |
0.0000 |
| 363 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
1 |
0.0000 |
| 364 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 365 |
RASH |
12 |
0.0000 |
| 366 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 367 |
ACCIDENTAL OVERDOSE |
1 |
0.0000 |
| 368 |
AGITATION |
2 |
0.0000 |
| 369 |
DYSURIA |
1 |
0.0000 |
| 370 |
HYPERSENSITIVITY |
5 |
0.0000 |
| 371 |
DYSARTHRIA |
1 |
0.0000 |
| 372 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 373 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 374 |
CONDITION AGGRAVATED |
8 |
0.0000 |
| 375 |
PAIN |
16 |
0.0000 |
| 376 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 377 |
DRUG INTERACTION |
4 |
0.0000 |
| 378 |
FEELING ABNORMAL |
6 |
0.0000 |
| 379 |
SOMNOLENCE |
5 |
0.0000 |
| 380 |
FATIGUE |
19 |
0.0000 |
| 381 |
LUNG NEOPLASM MALIGNANT |
1 |
0.0000 |
| 382 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 383 |
POLLAKIURIA |
1 |
0.0000 |
| 384 |
LOSS OF CONSCIOUSNESS |
3 |
0.0000 |
| 385 |
HYPOACUSIS |
1 |
0.0000 |
| 386 |
DYSPNOEA |
13 |
0.0000 |
| 387 |
INSOMNIA |
6 |
0.0000 |
| 388 |
MATERNAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 389 |
SKIN IRRITATION |
1 |
0.0000 |
| 390 |
TINNITUS |
1 |
0.0000 |
| 391 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 392 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 393 |
ARRHYTHMIA |
1 |
0.0000 |
| 394 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 395 |
FLUSHING |
2 |
0.0000 |
| 396 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 397 |
INFLAMMATION |
1 |
0.0000 |
| 398 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 399 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 400 |
NERVOUSNESS |
1 |
0.0000 |
| 401 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 402 |
OEDEMA |
1 |
0.0000 |
| 403 |
COUGH |
5 |
0.0000 |
| 404 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 405 |
ASTHMA |
2 |
0.0000 |
| 406 |
COVID-19 |
3 |
0.0000 |
| 407 |
BONE PAIN |
1 |
0.0000 |
| 408 |
PRODUCT DOSE OMISSION ISSUE |
5 |
0.0000 |
| 409 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 410 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 411 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 412 |
PRODUCT USE ISSUE |
3 |
0.0000 |
| 413 |
INTENTIONAL OVERDOSE |
1 |
0.0000 |
| 414 |
HYPERHIDROSIS |
2 |
0.0000 |
| 415 |
DEVICE DIFFICULT TO USE |
1 |
0.0000 |
| 416 |
INFUSION RELATED REACTION |
1 |
0.0000 |
| 417 |
DRY SKIN |
2 |
0.0000 |
| 418 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 419 |
MULTIPLE SCLEROSIS RELAPSE |
1 |
0.0000 |
| 420 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 421 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 422 |
MOBILITY DECREASED |
1 |
0.0000 |
| 423 |
ASTHENIA |
5 |
0.0000 |
| 424 |
HOT FLUSH |
1 |
0.0000 |
| 425 |
DIABETES MELLITUS |
1 |
0.0000 |
| 426 |
INJECTION SITE PAIN |
4 |
0.0000 |
| 427 |
BACK PAIN |
3 |
0.0000 |
| 428 |
ARTHRITIS |
1 |
0.0000 |
| 429 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 430 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 431 |
THROMBOSIS |
1 |
0.0000 |
| 432 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 433 |
URTICARIA |
2 |
0.0000 |
| 434 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 435 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 436 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 437 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 438 |
DEVICE ISSUE |
1 |
0.0000 |
| 439 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 440 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 441 |
MUSCLE SPASMS |
2 |
0.0000 |
| 442 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 443 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 444 |
CONTUSION |
1 |
0.0000 |
| 445 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 446 |
DYSPEPSIA |
1 |
0.0000 |
| 447 |
HYPOTENSION |
2 |
0.0000 |
| 448 |
DIARRHOEA |
6 |
0.0000 |
| 449 |
OVERDOSE |
2 |
0.0000 |
| 450 |
JOINT SWELLING |
1 |
0.0000 |
| 451 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 452 |
DEHYDRATION |
1 |
0.0000 |
| 453 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 454 |
INFECTION |
1 |
0.0000 |
| 455 |
HOSPITALISATION |
1 |
0.0000 |
| 456 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 457 |
FALL |
2 |
0.0000 |
| 458 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 459 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 460 |
ANAEMIA |
1 |
0.0000 |
| 461 |
ALOPECIA |
1 |
0.0000 |
| 462 |
DEPRESSION |
1 |
0.0000 |
| 463 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 464 |
DECREASED APPETITE |
1 |
0.0000 |
| 465 |
ABDOMINAL PAIN |
1 |
0.0000 |
| 466 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 467 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 468 |
PNEUMONIA |
1 |
0.0000 |
| 469 |
PYREXIA |
1 |
0.0000 |